SCellex
Novel high-throughput spatial transcriptomics: a 160,000-picowell chip + colour-coded beads create visual coordinates read by AI from microscope images → single-cell resolution in tissue, in situ. Cancer research. Univ. of Helsinki roots (founded 2018). NOTE: the company entered corporate restructuring (yrityssaneeraus) on 18.6.2026 and continues to operate.
The row
- Stage
- Pre-revenue — No sales yet
- Location
- Helsinki
- Founded
- 2018
- Research origin
- Univ. of Helsinki
- Business ID
- 2938279-4 · Finnish trade register
- Funding
- Angel funding
Links
Where this sits on the map
SCellex is one of 33 companies in Therapeutics & Diagnostics. The others:
How this row was decided
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗